Vasily Shuvaev
Russian Medical Academy of Continuous Professional Education(RU)Ministry of Health of the Russian Federation(RU)Medical Radiological Research Center(RU)Institute of Atomic Energy(PL)National Research Nuclear University MEPhI(RU)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies
Most-Cited Works
- → Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase(2018)129 cited
- → National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)(2021)25 cited
- → Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia(2017)22 cited
- → Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib(2024)22 cited
- → Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop(2016)21 cited
- → PF-114: A 4th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1T315I